In the news · 48h FDA 39 Eli Lilly 19 Roche 9 Merck & Co. (MSD) 8 Johnson & Johnson 4 AbbVie 3 AstraZeneca 3 Novo Nordisk 3

Company

Eli Lilly

Maker of Mounjaro and Zepbound, diabetes and obesity leader.

Approvals 6 Trials 7 Deals 5 Pricing 1

Now

Approvals & regulatory · 12h ago

U.S. Food and Drug Administration (FDA) approves Lilly's Onswik™ (insulin efsitora alfa-gobe), a once-weekly basal insulin injection treatment for adults living with type 2 diabetes

4 outlets Eli Lilly FDA

Trials & R&D · 11h ago

Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly

1 outlet Eli Lilly

Approvals & regulatory · 11h ago

FDA slams GLP-1 compounder over risk of contaminating drugs ‘with filth’

1 outlet GLP-1 & obesity drugs Eli Lilly FDA

Approvals & regulatory · 14h ago

Eli Lilly’s weekly insulin shot cleared by FDA, setting up another front in Novo rivalry

2 outlets Eli Lilly FDA

Deals & business · 11h ago

Lilly Again Looks to China for New Drugs, Paying InnoCare $100M to Start R&D Pact

1 outlet Eli Lilly

Deals & business · 14h ago

Lilly extends China innovation push in $3.35B Innocare deal

1 outlet Eli Lilly

Approvals & regulatory · 14h ago

Regulatory: FDA nods for Intrabio, Nuvation, Fempulse, Xenix and more

1 outlet Eli Lilly AstraZeneca

Approvals & regulatory · 14h ago

Awiqli insulin, this time for Lilly, with FDA-cleared Onswik

1 outlet Eli Lilly FDA

Deals & business · 16h ago

Lilly’s latest China drug deal; Immunovant’s setback in lupus

1 outlet Eli Lilly Vertex

Approvals & regulatory · 16h ago

Eli Lilly outlays $3.35bn for secretive drug discovery pact with China’s InnoCare

1 outlet Eli Lilly

Approvals & regulatory · 17h ago

STAT+: Pharmalittle: We’re reading about the FDA commissioner nominee, a Lilly partnership in China, and more

1 outlet Eli Lilly FDA

Approvals & regulatory · 17h ago

Lilly's rival to Novo's new Awiqli insulin gets FDA approval

1 outlet Eli Lilly Novo Nordisk

Deals & business · 20h ago

InnoCare inks licensing deal with Eli Lilly worth up to $3.35B

2 outlets Eli Lilly

Trials & R&D · 18h ago

Lilly sets aside up to $3.25B to tackle critical unmet need targets with InnoCare

1 outlet Eli Lilly

Deals & business · 19h ago

Eli Lilly and InnoCare Pharma agree on $3.3bn drug research deal

1 outlet Eli Lilly

Approvals & regulatory · 19h ago

Lilly wins FDA nod for once-weekly insulin product, Onswik

1 outlet Eli Lilly FDA

Trials & R&D · 19h ago

Lilly forges $3.35bn alliance with China's InnoCare

1 outlet Eli Lilly

Deals & business · yesterday

Growth mode: 3 biotechs that are staffing up after series B raises

1 outlet Eli Lilly Johnson & Johnson

Deals & business · yesterday

Lilly puts up $100M, plus billions on the backend, to form 5-target deal with China's InnoCare

1 outlet Eli Lilly